EU centre calls for policies to help female drug users
Patterns of drug misuse in the
European Union are changing,
with a chronically ageing population among heroin addicts and
a wider use of cocaine, cannabis,
and combinations of amphetamines, ecstasy, and medicines.
The picture is contained in
the annual report of the European Union's European Monitoring Centre for Drugs and
Drug Addiction in Lisbon. It
estimates that the number of
drug addicts has remained stable
at around 1.5 million, but within
that figure lie different trends.
The numbers of people starting treatment for heroin are
decreasing and users tend to be
older with serious social and
psychiatric problems. In contrast, new admissions for cocaine
or cannabis use are rising, especially among the young.
Among schoolchildren,
experience of cannabis ranges
from 5-7% in Portugal and Sweden to 30-40% in the Republic
of Ireland, the Netherlands, and
the United Kingdom.
The centre makes a plea for
more tailor-made responses to
take account of female drug
users who fear they may lose
their children if they enrol for
treatment. It also highlights the
need for policies addressed at
women who finance their habit
through the sex industry. Although 12 EU countries have
specific programmes in this
area, Belgium, Finland, and Sweden do not.
The report draws attention to
the drug prevention schemes in
Austria, Germany, and Sweden
directed at very young women
and schoolgirls to prevent them
from picking up the habit from
older boyfriends.
Given that at least 45 million
people in the European Union
have tried cannabis at least once
and that around 15 million have
done so in the past year, it is not
surprising that policymakers are
targeting the phenomenon.
But the European monitoring centre's director, Georges
Estievenart, criticised a zero tolerance approach. "No one really
sees this as a crime to be
repressed with an iron fist," he
said.

The Danes top the table for cannabis use, with the former East Germany trailing the field
Rory Watson, Brussels
studentBMJ 2000;08:395-434 November ISSN 0966-6494